Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mao Okada

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
The Journal of Dermatology|January 27, 2026
Effectiveness of Combinational Therapy With Tapinarof and Narrowband Ultraviolet B for Atopic DermatitisMao Okada-Jokaku, Yushiro Ohara, Chiharu Kido, et al.
Frontiers in Medicine|October 9, 2024
Regional diversity in drug-induced lung diseases among the USA, European Union, and JapanJun Sato, Ryo Sadachi, Takafumi Koyama, et al.
International Journal of Molecular Sciences|June 26, 2025
First Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma with Tasurgratinib Following Regulatory Approval: A Case Report from Clinical PracticeYuta Maruki, Chigusa Morizane, Mao Okada, et al.
Investigational New Drugs|April 14, 2026
A phase I study of TRK-950, an Anti-CAPRIN-1 antibody, as monotherapy and in combination with nivolumab in Japanese patients with advanced solid tumorsTakafumi Koyama, Kan Yonemori, Jun Sato, et al.
Applied Optics|April 18, 2017
Multi-point temperature sensing using a linear-cavity lasing systemHiroki Kishikawa, Mao Okada, Kazuto Takahashi, et al.
Japanese Journal of Clinical Oncology|March 1, 2026
Study protocol for a phase I investigator-initiated clinical trial of E7820 in Japanese patients with unresectable solid tumours: CIRCUS trial (NCCH2303)Mao Okada, Jun Sato, Chikako Funasaka, et al.
Japanese Journal of Clinical Oncology|May 8, 2024
Immune-related adverse event-associated sclerosing cholangitis due to immune checkpoint inhibitors: imaging findings and treatmentsKohei Okamoto, Susumu Hijioka, Yoshikuni Nagashio, et al.
Cancer Medicine|December 9, 2024
Prevalence of HER3 Expression in Pancreatic Cancer Patients Treated With Systemic ChemotherapyTomoyuki Satake, Chigusa Morizane, Mao Okada, et al.
Cancer Science|January 20, 2025
A Phase I, First-In-Human Study of CBA-1205, an Anti-DLK1 Monoclonal Antibody, in Patients With Advanced Solid TumorsYuki Katsuya, Masafumi Ikeda, Takafumi Koyama, et al.
Diagnostics (Basel, Switzerland)|April 3, 2020
Use of the Serum <i>Wisteria floribunda</i> Agglutinin-Positive Mac2 Binding Protein as a Marker of Gastroesophageal Varices and Liver-Related Events in Chronic Hepatitis C PatientsTsuguru Hayashi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
The Journal of Dermatology|January 27, 2026
Effectiveness of Combinational Therapy With Tapinarof and Narrowband Ultraviolet B for Atopic DermatitisMao Okada-Jokaku, Yushiro Ohara, Chiharu Kido, et al.
Frontiers in Medicine|October 9, 2024
Regional diversity in drug-induced lung diseases among the USA, European Union, and JapanJun Sato, Ryo Sadachi, Takafumi Koyama, et al.
International Journal of Molecular Sciences|June 26, 2025
First Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma with Tasurgratinib Following Regulatory Approval: A Case Report from Clinical PracticeYuta Maruki, Chigusa Morizane, Mao Okada, et al.
Investigational New Drugs|April 14, 2026
A phase I study of TRK-950, an Anti-CAPRIN-1 antibody, as monotherapy and in combination with nivolumab in Japanese patients with advanced solid tumorsTakafumi Koyama, Kan Yonemori, Jun Sato, et al.
Applied Optics|April 18, 2017
Multi-point temperature sensing using a linear-cavity lasing systemHiroki Kishikawa, Mao Okada, Kazuto Takahashi, et al.
Japanese Journal of Clinical Oncology|March 1, 2026
Study protocol for a phase I investigator-initiated clinical trial of E7820 in Japanese patients with unresectable solid tumours: CIRCUS trial (NCCH2303)Mao Okada, Jun Sato, Chikako Funasaka, et al.
Japanese Journal of Clinical Oncology|May 8, 2024
Immune-related adverse event-associated sclerosing cholangitis due to immune checkpoint inhibitors: imaging findings and treatmentsKohei Okamoto, Susumu Hijioka, Yoshikuni Nagashio, et al.
Cancer Medicine|December 9, 2024
Prevalence of HER3 Expression in Pancreatic Cancer Patients Treated With Systemic ChemotherapyTomoyuki Satake, Chigusa Morizane, Mao Okada, et al.
Cancer Science|January 20, 2025
A Phase I, First-In-Human Study of CBA-1205, an Anti-DLK1 Monoclonal Antibody, in Patients With Advanced Solid TumorsYuki Katsuya, Masafumi Ikeda, Takafumi Koyama, et al.
Diagnostics (Basel, Switzerland)|April 3, 2020
Use of the Serum <i>Wisteria floribunda</i> Agglutinin-Positive Mac2 Binding Protein as a Marker of Gastroesophageal Varices and Liver-Related Events in Chronic Hepatitis C PatientsTsuguru Hayashi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Pageof 5